PATENT CLAIM ANALYSIS

Application Number: 16059301
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["424", "133100"]

Abstract:
Provided herein are materials and methods for delivering immunoglobulins (e.g. therapeutic immunoglobulins) across the blood-brain barrier.

Claim (Index 11):
The peptide of  claim 1 , wherein the blood-brain barrier agent comprises a sequence having at least 80% sequence identity to: (SEQ\u2003ID\u2003NO:\u20034) L-R-V-R-L-A-S-H-L-R-K-L-R-K-R-L-L-R-D-A.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.11111
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15246232', '13229900', '16092671', '15579988', '16092680']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7613954967236849
- 35 USC 102 Novelty (BERT): 0.5976583575571717
- Combined Prediction Score: 0.7450217828070336
- Mean Citation Score: 383.311028
- Max Citation Score: 531.6647
- Similarity Product: 459.3499149486423

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test